Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Immunomedics Inc
(NQ:
IMMU
)
87.86
USD
UNCHANGED
Last Price
Updated: 7:41 PM EDT, Oct 22, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Immunomedics Inc
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Portnoy Law Firm: Tactile Systems Technology, Inc., Pintec Technologies Holdings Limited, and Immunomedics, Inc. Investors Have Limited Amount of Time Before Class Action Deadline
November 27, 2020
Investors with losses are encouraged to contact Attorney Lesley F. Portnoy.
From
GlobeNewswire News Releases
BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam
November 05, 2020
From
InvestorBrandNetwork
Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
November 05, 2020
From
GlobeNewswire News Releases
Gilead Sciences Completes Acquisition of Immunomedics, Inc.
October 23, 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire Immunomedics, Inc. (Nasdaq: IMMU) for approximately $21 billion in the aggregate.
From
Business Wire News Releases
ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics
October 20, 2020
ProteoNic BV, a leading provider of technology and services in the field of production of biologics, today announced it has licensed its premium 2G UNic™ technology for boosting therapeutic protein...
From
PR Newswire
Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma
October 12, 2020
From
GlobeNewswire News Releases
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - CBMG, VRTU, MR, IMMU, JCAP
October 05, 2020
Halper Sadeh LLP, a global investor rights law firm, is investigating:
From
PR Newswire
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations
October 02, 2020
From
PR Newswire
Moore Kuehn Encourages IMMU, MOBL, MR, and SCBH Investors to Contact Law Firm
October 01, 2020
From
GlobeNewswire News Releases
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, RST, IMMU, VAR
September 26, 2020
From
ACCESSWIRE
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations
September 25, 2020
From
PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations
September 25, 2020
From
PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts
September 22, 2020
From
GlobeNewswire News Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, AKCA, VRTU, IMMU
September 21, 2020
From
ACCESSWIRE
(IMMU) Alert: Johnson Fistel Investigates Proposed Sale of Immunomedics; Is $88 a Fair Price?
September 20, 2020
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Immunomedics Inc. (NASDAQ: IMMU) ("Immunomedics" or the "Company") breached their...
From
PR Newswire
Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer
September 19, 2020
From
GlobeNewswire News Releases
Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer
September 19, 2020
From
GlobeNewswire News Releases
Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
September 18, 2020
Results include partial responses in small cohort of patients with brain metastasis from breast cancer (BMBC) and recurrent glioblastoma (rGBM)
From
GlobeNewswire News Releases
Lifshitz Law Firm, P.C. Announces Investigation of Immunomedics, Inc. (NASDAQ: IMMU), Livongo Health, Inc. (NASDAQ:LVGO), Varian Medical Systems, Inc. (NYSE: VAR) and Virtusa Corporation (NASDAQ: VRTU
September 16, 2020
From
GlobeNewswire News Releases
Nanomedicine Seen As A Promising Approach For Diagnosis and Treatment Against COVID
September 16, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Nanomedicine Seen As A Promising Approach For Diagnosis and Treatment Against COVID
September 16, 2020
- Financialnewsmedia.com News Commentary
From
PR Newswire
Moore Kuehn Encourages IMMU, ONDK, VRTU, and OTEL Investors to Contact Law Firm
September 15, 2020
Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to...
From
PR Newswire
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
September 15, 2020
Halper Sadeh LLP, a global investor rights law firm, is investigating:
From
PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Immunomedics, Inc.
September 14, 2020
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Immunomedics, Inc. ("IMMU" or the "Company") (NASDAQ: IMMU) in connection with...
From
PR Newswire
IMMUNOMEDICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Immunomedics - IMMU
September 14, 2020
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Immunomedics (NasdaqGS: IMMU) to Gilead...
From
Business Wire News Releases
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Immunomedics, Inc. Buyout
September 14, 2020
From
GlobeNewswire News Releases
Thinking about trading options or stock in Immunomedics, Oracle, Vir Biotechnology, United Airlines, or Tesla?
September 14, 2020
InvestorsObserver issues critical PriceWatch Alerts for IMMU, ORCL, VIR, UAL, and TSLA.
From
PR Newswire
Immunomedics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Immunomedics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – IMMU
September 13, 2020
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Immunomedics, Inc. (NASDAQ: IMMU) to Gilead Sciences, Inc. for $88.00 per share is fair to Immunomedics...
From
Business Wire News Releases
Gilead Sciences to Acquire Immunomedics
September 13, 2020
Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced today that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for...
From
Business Wire News Releases
Immunomedics Announces Key Oral Presentations at ESMO Virtual Congress 2020
September 09, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.